None · None

FORTREA HLDGS INC FTRE

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Company profile

Business mix

  • It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics.
  • The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services.
  • Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Current key questions

  • Can the company's products, services, or pipeline expand adoption within biotechnology?
  • How do reimbursement, regulation, clinical data, patents, and commercial execution affect growth?
  • Can margins and cash flow improve while funding research, manufacturing, or go-to-market investment?
Holders 2 Current sample portfolio
Public mentions 0 Videos / interviews / letters

Current firm holders

Firm Weight Value Filing period
Corvex Management Keith Meister 1.7% $43.7M 2026-03-31
Sessa Capital 0.8% $43.3M 2026-03-31

Recent trading changes over the last 4 quarters

Net buyers 1 Last 4 13F filing periods
Net reducers 1 Last 4 13F filing periods
Unchanged holders 1 Share count unchanged
Increase amount $1.6M Estimated from net added shares
Reduction amount $942,000 Estimated from net reduced shares
Net share change / base shares +0.8% +69,295 / 9,168,448
Corvex Management Keith Meister 4 filing periods
13F 2025-06-30 Filed 2025-08-14
Minor increase Shares 0.8% 13F value change -$11.5M
13F 2025-09-30 Filed 2025-11-14
Unchanged Shares 0.0% 13F value change $0
13F 2025-12-31 Filed 2026-02-17
Unchanged Shares 0.0% 13F value change $0
13F 2026-03-31 Filed 2026-05-15
Minor increase Shares 3.0% 13F value change -$34.0M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 4,474,898 Last 4 periods +169,295 (+3.8%) Total shares 4,644,193 Value $43.7M
Sessa Capital 4 filing periods
13F 2025-06-30 Filed 2025-08-13
Minor reduction Shares -14.9% 13F value change -$15.7M
13F 2025-09-30 Filed 2025-11-14
Unchanged Shares 0.0% 13F value change $0
13F 2025-12-31 Filed 2026-02-17
Unchanged Shares 0.0% 13F value change $0
13F 2026-03-31 Filed 2026-05-15
Major increase Shares 15.0% 13F value change -$25.6M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 4,693,550 Last 4 periods -100,000 (-2.1%) Total shares 4,593,550 Value $43.3M
Starboard Value Jeff Smith 3 filing periods
13F 2025-03-31 Filed 2025-05-15
New Shares - 13F value change +$39.8M
13F 2025-06-30 Filed 2025-08-14
Major reduction Shares -52.6% 13F value change -$27.4M
13F 2025-09-30 Filed 2025-11-14
Sold out Shares -100.0% 13F value change -$12.3M
Settlement As of 13F 2025-09-30 · Filed 2025-11-14
Base shares 0 Last 4 periods +0 (New) Total shares 0 Value $0

Recent mentions

No public mentions.